Dong D, Zhao M, Zhang J, Huang M, Wang Y, Qi L, Wan CF, Yu X, Song T. Neurolytic splanchnic nerve block and pain relief, survival, and quality of life in unresectable pancreatic cancer: a randomized controlled trial. Anesthesiology. 2021;135:689–98.
Fujii-Lau LL, Bamlet WR, Eldrige JS, Chari ST, Gleeson FC, Abu Dayyeh BK, Clain JE, Pearson RK, Petersen BT, Rajan E, Topazian MD, Vege SS, Wang KK, Wiersema MJ, Levy MJ. Impact of celiac neurolysis on survival in patients with pancreatic cancer. Gastrointest Endosc. 2015;82:46–56.
Article PubMed PubMed Central Google Scholar
Rathmell JP, Rickerson EM, Tulsky JA, Lillemoe KD. Reassessing the role for sympathetic neurolysis in patients with pancreatic cancer. Anesthesiology. 2021;135:573–5.
Fried LP, Tangen CM, Walston J, Newman AB, Hirsh C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Cerontol A Bio Sci Med Sci. 2001. https://doi.org/10.1093/Gerona/56.3.m146.
Anderson F, Downing GM, Hill J, Casorso L, Lerch N. Palliative performance scale (PPS): a new tool. J Palliat Care. 1996;12:5–11.
Article CAS PubMed Google Scholar
Morita T, Tsunoda J, Inoue S, Chihara S. The palliative prognostic index: a scoring system for survival prediction of terminally ill cancer patients. Support Care Cancer. 1999;7:128–33.
Article CAS PubMed Google Scholar
De Iaco F, Mannaioni G, Serra S, Finco G, Sartori S, Gandolfo E, Sansone P, Marinangelii F. Equianalgesia, opioid switch and opioid association in different clinical settings: a narrative review. Eur Rev Med Pharmacol Sci. 2022;26:2000–17.
Takakuwa O, Oguri T, Maeno K, Murase H, Asano T, Ichikawa H, Kawaguchi Y, Uemura T, Ohkubo H, Takemura M, Niimi A. Long-term use of a once-a day fentanyl citrate transdermal patch in lung cancer patients. Oncol Lett. 2015;9:2105–8.
Article CAS PubMed PubMed Central Google Scholar
Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs. 2005;14:798–804.
World Health Organization. Cancer pain relief. 2nd ed. Geneva: World Health Organization; 1996.
Mercadante S. Refractory cancer pain and intrathecal therapy: critical review of a systematic review. Pain Ther. 2023;12:645–54.
Article PubMed PubMed Central Google Scholar
Sjöberg M, Nitescu P, Appelgren L, Curelaru I. Long-term intrathecal morphine and bupivacaine in patients with refractory cancer pain. Results from a morphine: bupivacaine dose regimen of 0.5: 4.75 mg/ml. Anesthesiology. 1994;80:284–97.
Nitescu P, Appelgren L, Hultman E, Linder LE, Sjögern M, Curelaru I. Long-term, open catheterization of the spinal subarachnoid space for continuous infusion of narcotic and bupivacaine in patients with “refractory” cancer pain. a technique of catheterization and its problems and complications. Clin J Pain. 1991;7:143–61.
Article CAS PubMed Google Scholar
Arcidiacono PG, Calori G, Carrara S, McNicol ED, Testoni PA. Celiac plexus block for pancreatic cancer pain in adults. Cochrane Database syst Rev. 2011. https://doi.org/10.1002/14651858.CD007519.pub2.
Article PubMed PubMed Central Google Scholar
Yan BM, Myers RP. Neurolytic celiac plexus block for pain control in unresectable pancreatic cancer. Am J Gastroenterol. 2007;102:430–8.
Lillemoe KD, Cameron JL, Kaufman HS, Yeo CJ, Pitt HA, Sauter PK. Chemical splanchnicectomy in patients with unresectable pancreatic cancer: a prospective randomized trial. Ann Surg. 1993. https://doi.org/10.1097/00000658-199305010-00004.
Article PubMed PubMed Central Google Scholar
Süleyman Ozyalçin N, Talu GK, Camlica H, Erdine S. Efficacy of coeliac plexus and splanchnic nerve blockades in body and tail located pancreatic cancer pain. Eur J Pain. 2004;8:539–45.
Nomak H, Szwacka DM, Pater M, Mrugalski WK, Milcrarek MG, Staniszewska M, Jankowski R, Barciszewska AM. Holistic approach to the diagnosis and treatment of patients with tumor metastases to the spine. Cancers. 2022;14:3480.
Smith TJ, Staats PS, Deer T, Stearns LJ, Rauck RL, Boortz-Marx RL, Buchser E, Català E, Bryce DA, Coyne PJ, Pool GE, Implantable Drug Delivery System Study Group. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol. 2002. https://doi.org/10.1200/JCO.2002.02.118.
Davis MP, Walsh D, Lagman R, LeGrand SB. Randomized clinical trial of an implantable drug delivery system. J Clin Oncol. 2003;15:2800–1.
Ripamonti C, Brunelli C. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol. 2003;15:2801–2.
Comments (0)